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SUPPLEMENTAL TABLE 3 Cancer Incidence Rates and APC of Rates in Children and Adolescents (Ages 0–19 Years) by Race/Ethnicity, United States,
2001–2009
ICCC Group Non-Hispanic White Non-Hispanic Black Hispanic
Count Ratea APCb (95% CI) Count Ratea APCb (95% CI) Count Ratea APCb (95% CI)
All ICCC groups combined 74 965 180.03 0.0 (20.5 to 0.5) 13 180 130.08 1.5 (0.3 to 2.7)c 24 421 168.94 0.6 (0.0 to 1.3)
I Leukemias, myeloproliferative,
myelodysplastic diseases
18 364 44.89 20.2 (21.1 to 0.7) 2854 28.28 1.4 (20.2 to 3.0) 8433 56.62 1.3 (0.1 to 2.6)c
I(a) Lymphoid leukemias 13 291 32.69 20.1 (21.2 to 0.9) 1707 16.99 2.0 (20.4 to 4.5) 6326 42.25 1.6 (0.1 to 3.1)c
I(b) Acute myeloid leukemias 3149 7.58 20.8 (22.3 to 0.8) 735 7.25 20.3 (25.3 to 4.9) 1272 8.72 0.2 (21.7 to 2.1)
I(c) Chronic myeloproliferative diseases 864 2.04 0.7 (21.7 to 3.2) 202 1.97 — 360 2.51 1.9 (24.7 to 9.0)
I(d) Myelodysplastic syndrome,
other myeloproliferative
614 1.49 0.0 (25.8 to 6.2) 119 1.17 — 228 1.49 22.0 (26.5 to 2.8)
I(e) Unspeciﬁed and other
speciﬁed leukemias
446 1.08 20.7 (24.9 to 3.7) 91 0.90 — 247 1.65 3.0 (22.5 to 8.8)
II Lymphomas and reticuloendothelial
neoplasms
11 198 26.28 0.5 (20.3 to 1.3) 2223 21.76 2.4 (20.3 to 5.2) 3020 22.23 20.9 (21.9 to 0.2)
II(a) Hodgkin’s lymphomas 5921 13.68 0.3 (20.5 to 1.2) 1031 10.05 3.2 (0.4 to 6.1)c 1420 10.83 20.2 (22.5 to 2.1)
II(b) Non-Hodgkin’s lymphomas
(except Burkitt lymphoma)
3600 8.53 0.4 (21.0 to 1.7) 939 9.20 1.1 (22.6 to 4.9) 1089 7.99 20.2 (23.0 to 2.6)
II(c) Burkitt lymphoma 1202 2.91 0.4 (22.9 to 3.8) 161 1.60 — 252 1.77 5.6 (213.1 to 2.6)
II(d) Miscellaneous
lymphoreticular neoplasms
348 0.86 5.3 (20.3 to 11.2) 51 0.51 — 202 1.22 —
II(e) Unspeciﬁed lymphomas 127 0.30 — 41 0.40 — 57 0.41 —
III CNS and miscellaneous
intracranial and intraspinal
neoplasms
13 858 33.78 0.0 (21.2 to 1.3) 2338 23.27 1.1 (21.0 to 3.2) 3719 25.22 21.0 (22.6 to 0.6)
III(a) Ependymomas and choroid
plexus tumor
1091 2.66 21.4 (24.6 to 1.9) 199 1.98 21.7 (29.1 to 6.2) 407 2.68 22.3 (26.5 to 2.2)
III(b) Astrocytomas 7162 17.41 20.1 (21.5 to 1.3) 1116 11.09 2.1 (21.6 to 6.1) 1673 11.53 20.5 (22.8 to 1.9)
III(c) Intracranial and intraspinal
embryonal tumors
2809 6.92 20.1 (22.2 to 2.1) 417 4.16 21.4 (23.4 to 0.6) 875 5.76 22.1 (25.2 to 1.1)
III(d) Other gliomas 2356 5.72 1.2 (20.7 to 3.1) 439 4.39 2.1 (21.8 to 6.2) 628 4.32 21.4 (26.5 to 4.0)
III(e) Other speciﬁed intracranial/
intraspinal neoplasms
251 0.61 23.3 (28.9 to 2.7) 117 1.16 — 73 0.50 —
III(f) Unspeciﬁed intracranial
and intraspinal neoplasms
189 0.46 — 50 0.49 — 63 0.43 —
IV Neuroblastoma, other peripheral
nervous cell tumors
3893 9.70 20.9 (22.8 to 1.0) 719 7.15 1.3 (22.8 to 5.5) 920 5.40 22.3 (26.0 to 1.4)
IV(a) Neuroblastoma and
ganglioneuroblastoma
3807 9.49 21.0 (22.8 to 0.9) 698 6.95 1.3 (22.5 to 5.2) 893 5.21 22.9 (26.5 to 0.9)
IV(b) Other peripheral nervous
cell tumors
86 0.20 — 21 0.21 — 27 0.19 —
V Retinoblastoma 1034 2.58 20.6 (22.3 to 1.1) 359 3.55 20.1 (23.0 to 2.8) 600 3.43 20.7 (25.2 to 3.9)
VI Renal tumors 2778 6.90 20.1 (21.6 to 1.5) 831 8.30 2.9 (1.8 to 4.0)c 825 5.05 0.5 (23.0 to 4.0)
VI(a) Nephroblastoma, other
nonepithelial renal tumors
2548 6.36 20.3 (21.7 to 1.1) 706 7.08 2.8 (1.5 to 4.0)c 763 4.58 20.1 (23.6 to 3.6)
VI(b) Renal carcinomas 215 0.50 3.6 (22.5 to 10.1) 121 1.18 — 59 0.45 —
VI(c) Unspeciﬁed malignant
renal tumors
— — — — — — — — —
VII Hepatic tumors 826 2.02 1.0 (21.8 to 3.8) 150 1.48 — 363 2.25 3.5 (25.6 to 13.4)
VII(a) Hepatoblastoma 592 1.48 0.7 (22.6 to 4.1) 94 0.93 — 274 1.59 3.1 (26.5 to 13.7)
VII(b) Hepatic carcinomas 224 0.52 1.8 (23.7 to 7.5) 55 0.54 — 87 0.65 —
VII(c) Unspeciﬁed malignant
hepatic tumors
— — — — — — — — —
VIII Malignant bone tumors 3931 9.28 21.0 (22.2 to 0.2) 752 7.37 20.9 (24.8 to 3.3) 1255 9.49 0.5 (21.7 to 2.7)
VIII(a) Osteosarcomas 1967 4.63 20.7 (22.6 to 1.3) 601 5.89 21.1 (26.0 to 4.1) 770 5.87 0.8 (21.7 to 3.7)
PEDIATRICS Volume 134, Number 4, October 2014 SI1
ARTICLE
SUPPLEMENTAL TABLE 3 Continued
ICCC Group Non-Hispanic White Non-Hispanic Black Hispanic
Count Ratea APCb (95% CI) Count Ratea APCb (95% CI) Count Ratea APCb (95% CI)
VIII(b) Chondrosarcomas 172 0.40 — 23 0.22 — 38 0.29 —
VIII(c) Ewing tumor and related
sarcomas of bone
1544 3.67 21.5 (23.7 to 0.7) 65 0.64 — 349 2.60 0.7 (23.2 to 4.7)
VIII(d) Other speciﬁed
malignant bone tumors
179 0.42 — 39 0.38 — 60 0.45 —
VIII(e) Unspeciﬁed malignant
bone tumors
69 0.16 — 24 0.24 — 38 0.28 —
IX Soft tissue and other extraosseous
sarcomas
5027 12.04 0.0 (20.8 to 0.7) 1307 12.85 1.9 (20.1 to 3.9) 1628 11.49 20.2 (22.2 to 1.8)
IX(a) Rhabdomyosarcomas 1987 4.84 22.3 (24.7 to 0.2) 508 5.04 3.0 (21.8 to 7.9) 654 4.42 0.2 (24.7 to 5.4)
IX(b) Fibrosarcomas, peripheral
nerve, other ﬁbrous
555 1.32 2.2 (21.7 to 6.5) 149 1.46 — 198 1.40 26.7 (210.9 to 22.3)c
IX(c) Kaposi sarcoma — — — — — — — — —
IX(d) Other speciﬁed soft tissue
sarcomas
1977 4.67 0.9 (21.5 to 3.3) 504 4.93 1.4 (22.2 to 5.1) 616 4.53 0.6 (22.3 to 3.7)
IX(e) Unspeciﬁed soft tissue
sarcomas
501 1.19 3.1 (21.3 to 7.7) 134 1.31 — 156 1.11 —
X Germ cell, trophoblastic tumors,
neoplasms of gonads
4744 11.03 0.1 (21.6 to 1.7) 634 6.18 1.5 (20.1 to 3.0) 1900 14.26 1.8 (20.6 to 3.8)
X(a) Intracranial and intraspinal
germ cell tumors




551 1.35 20.6 (24.9 to 3.8) 148 1.45 — 246 1.66 24.5 (27.8 to 21.2)c
X(c) Malignant gonadal germ
cell tumors
3223 7.40 0.1 (21.7 to 1.8) 331 3.22 3.5 (20.8 to 8.0) 1304 9.96 2.5 (20.7 to 5.8)
X(d) Gonadal carcinomas 179 0.41 2.0 (22.4 to 6.5) 16 0.16 — 65 0.51 —
X(e) Other and unspeciﬁed
malignant gonadal tumors
122 0.28 — 42 0.41 — 42 0.32 —
XI Other malignant epithelial
neoplasms and melanomas
8984 20.74 0.3 (20.1 to 1.6) 934 9.09 1.4 (22.9 to 5.9) 1639 12.67 4.5 (2.7 to 7.1)c
XI(a) Adrenocortical carcinomas 100 0.24 — — — — 30 0.20 —
XI(b) Thyroid carcinomas 3393 7.81 4.0 (1.9 to 6.2)c 243 2.36 6.8 (0.7 to 13.2)c 838 6.53 9.1 (5.4 to 12.8)c
XI(c) Nasopharyngeal
carcinomas
141 0.33 — 176 1.71 — 61 0.48 —
XI(d) Malignant melanomas 3499 8.08 23.5 (26.3 to 20.5)c 52 0.51 — 218 1.64 22.0 (25.7 to 1.9)
XI(e) Skin carcinomas 38 0.09 — — — — — — —
XI(f) Other and unspeciﬁed
carcinomas
1813 4.19 1.0 (20.3 to 2.2) 447 4.35 20.6 (24.5 to 3.4) 485 3.78 1.1 (21.9 to 4.1)
XII Other and unspeciﬁed
malignant neoplasms
328 0.78 21.3 (25.6 to 3.2) 79 0.77 — 119 0.83 —
a Rates are per million and were age-adjusted to the 2000 US standard population (19 age groups, Census P25-1130) standard. Rate statistics were not displayed if case count was,16 cases.
b APCs were calculated by using weighted least squares method. Statistical signiﬁcance was determined if the 95% CI of APC did not include zero (P, .05). APC was not calculated if case count
was ,16 cases in any 1 year. Some signiﬁcant values appear to include zero because APC was rounded to the nearest 10th.
c Denotes signiﬁcant APC.
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SUPPLEMENTAL TABLE 4 Cancer Incidence Rates and APC of Rates in Children and Adolescents
(Ages 0–19 Years) by Region and by Race or Ethnicity, United States,
2001–2009
White African American
Count Ratea APCb (95% CI) Count Ratea APCb (95% CI)
Total 97 765 177.91 0.0 (20.5 to 0.5) 13 779 127.29 1.3 (0.2 to 2.5)c
Northeast 19 148 189.93 0.1 (20.5 to 0.8) 2859 135.88 0.5 (20.5 to 1.5)
Midwest 23 857 174.84 0.1 (20.4 to 0.6) 2839 124.09 0.1 (22.3 to 2.6)
South 29 430 174.72 0.0 (20.7 to 0.7) 6766 129.18 2.6 (1.3 to 3.8)c
West 25 330 176.34 20.1 (21.1 to 1.0) 1315 109.97 20.4 (22.2 to 1.5)
Non-Hispanic Hispanic
Count Ratea APCb (95% CI) Count Ratea APCb (95% CI)
Total 95 716 171.66 0.3 (20.2 to 0.7) 24 421 168.94 0.6 (0.0 to 1.3)
Northeast 20 452 185.16 0.2 (20.6 to 1.1) 3247 170.86 0.3 (21.3 to 2.0)
Midwest 25 952 171.57 0.3 (20.5 to 1.0) 2304 162.76 0.9 (21.6 to 3.5)
South 29 692 162.39 0.7 (0.0 to 1.5)c 8281 177.72 20.3 (21.1 to 0.5)
West 19 620 173.62 20.3 (21.3 to 0.7) 10 589 163.47 1.3 (0.1 to 2.5)c
a Rates are per million and were age-adjusted to the 2000 US standard population (19 age groups, Census P25-1130)
standard. Rate statistics were not displayed if case count was ,16 cases.
b APCs were calculated by using weighted least squares method. Statistical signiﬁcance was determined if the 95% CI of APC
did not include zero (P , .05). APC was not calculated if case count was ,16 cases in any 1 year. Some signiﬁcant values
appear to include zero because APC was rounded to the nearest 10th.
c Denotes signiﬁcant APC.
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